Table 2.
Variable | Hazard Ratio | 95% CI | BIF | P |
---|---|---|---|---|
Discovery cohort | ||||
TP53 mutation | 4.39 | 1.70 to 11.29 | 95.7 | .002 |
LCA v classic | 1.07 | 0.39 to 2.90 | 20.9 | .90 |
Desmoplastic v classic | 0.45 | 0.17 to 1.22 | 54.0 | .11 |
Sex (male v female) | 1.21 | 0.56 to 2.58 | 24.3 | .63 |
M+ | 0.38 | 0.11 to 1.37 | 58.6 | .14 |
Age < 3 years | 1.41 | 0.51 to 3.87 | 25.1 | .51 |
Validation cohort | ||||
TP53 mutation | 14.7 | 3.44 to 62.9 | 97.6 | < .001 |
LCA v classic | 2.90 | 0.79 to 10.6 | 47.1 | .11 |
Desmoplastic v classic | 0.41 | 0.08 to 2.14 | 43.9 | .29 |
Sex (male v female) | 0.71 | 0.24 to 2.11 | 24.4 | .54 |
M+ | 26.4 | 5.96 to 117.5 | 99.4 | < .001 |
Age < 3 years | 4.15 | 0.93 to 18.6 | 60.7 | .062 |
Abbreviations: BIF, bootstrap inclusion frequency; LCA, large cell/anaplastic; SHH, sonic hedgehog.